genazopt plus eye suspension 5ml ophthalmic suspension
brinzolamide usp and brimonidine tartrate bp - ophthalmic suspension - brinzolamide usp 1% and brimonidine tartrate bp - brinzolamide combinations
brinzolamide ophthalmic suspension 1% "senju" (ブリンゾラミド懸濁性点眼液1%「センジュ」)
senju pharmaceutical co.,ltd. - brinzolamide - white to faintly yellowish ophthalmic suspension
brinzolamide ophthalmic suspension 1% "nitto" (ブリンゾラミド懸濁性点眼液1%「ニットー」)
nitto medic co., ltd. - brinzolamide - white to faintly yellowish white ophthalmic suspension, (cap) white, (label) white, (body) clear
azopt 10mgml ophthalmic suspension
novartis corporation (malaysia) sdn. bhd. - brinzolamide -
azopt 10mgml eye drops
novartis pharmaceuticals uk ltd - brinzolamide - eye drops - 10mg/1ml
azopt ophthalmic suspension 1%
novartis (singapore) pte ltd - brinzolamide - solution - 10 mg/ml - brinzolamide 10 mg/ml
azarga 10mgml + 5mgml eye drops suspension
novartis (singapore) pte ltd - brinzolamide; timolol maleate 6.8mg/ml eqv timolol (as free base) - suspension, sterile - 10mg/ml - brinzolamide 10mg/ml; timolol maleate 6.8mg/ml eqv timolol (as free base) 5mg/ml
simbrinza
novartis europharm limited - brinzolamide, brimonidine tartrate - ocular hypertension; glaucoma, open-angle - ophthalmologicals - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.
azopt
novartis new zealand ltd - brinzolamide 1%; - eye drops, suspension - 1 % - active: brinzolamide 1% excipient: benzalkonium chloride carbomer disodium edetate dihydrate hydrochloric acid mannitol purified water sodium chloride sodium hydroxide tyloxapol - latest regulatory activity
azarga eye drops eye drops, suspension
novartis pharma ag litchtstrasse 35, 4056 basel, switzerland - brinzolamide, timolol maleate - eye drops, suspension - one ml of suspension contains 10 mg brinzolamide - brinzolamide combinations